Key result
Novel tracer [18F]AMBF3Los demonstrates high AT1R affinity and specific renal uptake on PET.
Why the study?
Monitoring AT1R biodistribution using PET could provide a valuable tool to assess the functionality of the renin-angiotensin system in cardiovascular diseases.
[18F]AMBF3Los demonstrates high binding affinity for AT1R, suggesting its potential as a novel PET tracer for molecular imaging of the renin-angiotensin system.
Answers are grounded in this paper and cite their sources.
May support preclinical AT1R PET imaging; leaves open human translation and clinical utility.
Losartan is widely used in clinics to treat cardiovascular related diseases by selectively blocking the angiotensin II type 1 receptors (AT1Rs), which regulate the renin-angiotensin system (RAS). Therefore, monitoring the physiological and pathological biodistribution of AT1R using positron emission tomography (PET) might be a valuable tool to assess the functionality of RAS. Herein, we describe the synthesis and characterization of two novel losartan derivatives PET tracers, [18F]fluoroethyl-losartan ([18F]FEtLos) and [18F]ammoniomethyltrifluoroborate-losartan ([18F]AMBF3Los). [18F]FEtLos was radiolabeled by 18F-fluoroalkylation of losartan potassium using the prosthetic group 2-[18F]fluoroethyl tosylate; whereas [18F]AMBF3Los was prepared following an one-step 18F-19F isotopic exchange reaction, in an overall yield of 2.7 ± 0.9% and 11 ± 4%, respectively, with high radiochemical purity (>95%). Binding competition assays in AT1R-expressing membranes showed that AMBF3Los presented an almost equivalent binding affinity (Ki 7.9 nM) as the cold reference Losartan (Ki 1.5 nM), unlike FEtLos (Ki 2000 nM). In vitro and in vivo assays showed that [18F]AMBF3Los displayed a good binding affinity for AT1R-overexpressing CHO cells and was able to specifically bind to renal AT1R. Hence, our data demonstrate [18F]AMBF3Los as a new tool for PET imaging of AT1R with possible applications for the diagnosis of cardiovascular, inflammatory and cancer diseases.
No takes yet. Share an insight, caveat, or question.
Pijeira et al. (2020) studied Molecular imaging of Angiotensin II Type 1 Receptors (AT1R). [18F]AMBF3Los and [18F]FEtLos vs. Cold reference Losartan potassium (and 18 mg/kg co-injected for in vivo AT1R blocking) was evaluated on AT1R binding affinity (Ki, nM) in human AT1R membrane competition assays (p=<0.01). [18F]AMBF3Los demonstrated high AT1R binding affinity, 11% radiochemical yield, and receptor-specific renal cortex PET uptake unlike [18F]FEtLos (Ki 2000 nM).
Synapse has enriched 10 related papers. Consider them for comparative context: